The antihyperalgesic effect of cytidine-5′-diphosphate-choline in neuropathic and inflammatory pain models

Behavioural Pharmacology

Volumn 22, Issue 5-6, 2011, Pages 589-598

  Bagdas, Deniz ^a   Sonat, Fusun Ak ^a   Hamurtekin, Emre ^b   Sonal, Songul ^a   Gurun, Mine Sibel ^b  

^a Faculty of Veterinary Medicine   (Turkey)

^b ULUDAG UNIVERSITY   (Turkey)

Author keywords

a7 nicotinic receptors; allodynia; c aminobutyric acid receptors; choline; cholinergic; cytidine 5 diphosphate choline; hyperalgesia; inflammatory pain; neuropathic pain; opioid receptors

Indexed keywords

3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; ALPHA BUNGAROTOXIN; ATROPINE; BUNGAROTOXIN RECEPTOR; CARRAGEENAN; CHOLINE; CITICOLINE; HEMICHOLINIUM 3; MECAMYLAMINE;

ANALGESIC ACTIVITY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG DOSE COMPARISON; DRUG MECHANISM; HYPERALGESIA; INFLAMMATION; MALE; NERVE COMPRESSION; NEUROPATHIC PAIN; NONHUMAN; RAT;

ANALGESICS; ANIMALS; CHOLINE; CYTIDINE DIPHOSPHATE CHOLINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERALGESIA; INFLAMMATION; MALE; NEURALGIA; PAIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-B; RECEPTORS, NICOTINIC; RECEPTORS, OPIOID; TIME FACTORS;

EID: 80051925529     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32834a1efb     Document Type: Article

References (75)

1. Abe K, Ishida K, Shigena T, Taguchi K, Miyatake T (2002). Effect of morphine-induced antinociception is altered by AF64A-induced lesions on cholinergic neurons in rat nucleus raphe magnus. Acta Pharmacol Sin 23:961-966. (Pubitemid 35285176)
2. Adibhatla RM, Hatcher JF (2002). Citicoline mechanisms and clinical efficacy in cerebral ischemia. J Neurosci Res 70:133-139.
3. Adibhatla RM, Hatcher JF (2005). Cytidine 50-diphosphocholine (CDP-choline) in stroke and other CNS disorders. Neurochem Res 30:15-23. (Pubitemid 40254200)
4. Alkondon M, Albuquerque EX (1993). Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functionalevidence for distinct structural subtypes. J Pharmacol Expl Ther 265:1455-1473. (Pubitemid 23321055)
5. Alkondon M, Albuquerque EX (2001). Nicotinic acetylcholine receptor alpha7 and alpha3beta4 subtypes differentially control GABAergic input to CA1 neurons in rat hippocampus. J Neurophysiol 86:3043-3055. (Pubitemid 33139070)
6. Alkondon M, Pereira EFR, Cortes WS, Maelicke A, Albuquerque EX (1997). Choline is a selective agonist of a7 nicotinic acetytlcholine receptors in rat brain neurons. Eur J Neurosci 9:2734-2742. (Pubitemid 28082962)
7. Alkondon M, Pereira EF, Eisenberg HM, Albuquerque EX (1999). Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices. J Neurosci 19:2693-2705. (Pubitemid 29162417)
8. Alkondon M, Braga MF, Pereira EF, Maelicke A, Albuquerque EX (2000). Alpha7 nicotinic acetylcholine receptors and modulation of gabaergic synaptic transmission in the hippocampus. Eur J Pharmacol 393:59-67. (Pubitemid 30193401)
9. Amenta F, Parnetti L, Gallai V, Wallin A (2001). Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches? Mech Ageing Dev 16:2025-2040. (Pubitemid 32925112)
10. Arslan BY, Ulus IH, Savci V, Kiran BK (1991). Effects of intracerebroventricular injected choline on cardiovascular functions and sympathoadrenal activity. J Cardiovasc Pharmacol 17:814-821.
11. Bartolini A, Ghelardini C, Fantetti L, Malcangio M, Malmberg-Aiello P, Giotti A (1992). Role of muscarinic receptor subtypes in central antinociception. Br J Pharmacol 105:77-82.
12. Beilin B, Nemirovski AY, Zeidel A, Maibord V, Zelman V, Katz RL (1997). Systemic physostigmine increases the antinociceptive effect of spinal morphine. Pain 70:217-221. (Pubitemid 27179634)
13. Bennett GJ, Xie YK (1988). A peripheral mononeuropathy in rat that producesdisorders of pain sensation like those seen in man. Pain 33:87-107.
14. Bouaziz H, Tong C, Yoon Y, Hood DD, Eisenach JC (1996). Intravenous opioids stimulate norepinephrine and acetylcholine release in spinal cord dorsal horn. Systematic studies in sheep and an observation in a human. Anesthesiology 84:143-154.
15. Cacabelos R, Alvarez XA, Franco-Maside A, Fernandez-Novoa L, Caamano J (1993). Effect of CDP-choline on cognition and immune function in Alzheimer's disease and multiinfarct dementia. Ann N Y Acad Sci 695:321-323. (Pubitemid 23348285)
16. Cacabelos R, Alvarez XA, Fernandez-Novoa L, Lombardi VR (2000). A pharmacogenomic approach to Alzheimer's disease. Acta Neurol Scand Suppl 176:12-19. (Pubitemid 32156165)
17. Carlezon WA, Pliakas AM, Parow AM, Detke MJ, Cohen BM, Renshaw PF (2002). Antidepressant-like effects of cytidine in the forced swim test in rats. Biol Psychiatry 51:882-891.
18. Cavun S, Savci V (2004). CDP-choline increases plasma ACTH and potentiates the stimulated release of GH, TSH and LH: the cholinergic involvement. Fundamen Clin Pharmacol 18:513-523. (Pubitemid 39468959)
19. Cohen EL, Wurtman RJ (1975). Brain acetylcholine: increase after systemic choline administration. Life Sciences 16:1095-1102.
20. Cucchiaro G, Xiao Y, Gonzalez-Sulser A, Kellar KJ (2008). Analgesic effects of Sazetidine-A, a new nicotinic cholinergic drug. Anesthesiology 109: 512-521.
21. D'Orlando KJ, Sandage BW Jr. (1995). Citicoline (CDP-choline): mechanisms of action and effects in ischemic brain injury. Neurol Res 17:281-284.
22. Damaj MI, Fe-Yn M, Glassco W, Glennon RA, Martin BR (1998). Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice. J Pharmacol Exp Ther 284:1058-1065. (Pubitemid 28130835)
23. Damaj MI, Meyer EM, Martin BR (2000). The antinociceptive effects of alpha7 nicotinic agonists in an acute pain model. Neuropharmacology 39:2785-2791.
24. Dani JA, Bertrand D (2007). Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 47:699-729.
25. Decker MW, Rueter LE, Bitner RS (2004). Nicotinic acetlycholine receptor agonists: a potential new class of analgesics. Curr Top Med Chem 4:369-384. (Pubitemid 38842575)
26. Drisdel RC, Gren WN (2000). Neuronal alpha-bungarotoxin receptors are alpha 7 subunit homomers. J Neurosci 20:133-139. (Pubitemid 30220499)
27. Enna SJ, McCarson KE (2006). The role of GABA in the mediation and perception of pain. Adv Pharmacol 54:1-27.
28. Flores CM (2000). The promise and pitfalls of a nicotinic cholinergic approach to pain management. Pain 88:1-6.
29. Fukui M, Nakagawa T, Minami M, Satoh M (2001). Antinociceptive effects of intracerebroventricularly administered P2 purinoceptor agonists in the rat. Eur. J Pharmacol 419:25-31. (Pubitemid 32441646)
30. Fukui M, Nakagawa T, Minami M, Satoh M, Kaneko S (2006). Inhibitory role of supraspinal P2 x 3/P2 x 2/3 subtypes on nociception in rats. Mol Pain 2:19.
31. Gurun MS, Leinbach R, Moore L, Lee CS, Owen MD, Eisenach JC (1997). Studies on safety of paraben-containing neostigmine for intrathecal administration. Anesth Analg 85:31 7-323.
32. Gurun MS, Parker R, Eisenach JC, Vincler M (2009). The effect of peripherally administered CDP-choline in an acute inflammatory pain model: the role ofalpha7 nicotinic acetylcholine receptor. Anesth Analg 108:1680-1687.
33. Hamurtekin E, Gurun MS (2006). The antinociceptive effects of centrally administered CDP-choline on acute pain models in rats: The involvement of cholinergic system. Brain Res 1117:92-100. (Pubitemid 44573100)
34. Hamurtekin E, Bagdas D, Gurun MS (2007). Possible involvement of supraspinal opioid and GABA receptors in CDP-choline induced antinociception in acute pain models in rats. Neurosci Lett 420:116-121. (Pubitemid 46818674)
35. Houdi AA, Pierzchala K, Marson L, Palkovits M, Van Loon GR (1991). Nicotine-induced alteration in Tyr-Gly-Gly and Met-enkephalin in discrete brain nuclei reflects altered enkephalin neuron activity. Peptides 12:161-167.
36. Iversen L (2004). GABA pharmacology-what prospects for the future? Biocheml Pharmacol 68:1537-1540.
37. Kaya FN, Sahin S, Owen MD, Eisenach JC (2004). Epidural neostigmine produces analgesia but also sedation in women after cesarean delivery. Anesthesiology 100:381-386.
38. Kennedy C (2005). P2X receptors: targets for novel analgesics? Neuroscientist 11:345-356. (Pubitemid 41040863)
39. Koshimura K, Miwa S, Lee K, Hayashi Y, Hasegawa H, Hamahata K, etal. (1990). Effects of choline administration on in vivo release and biyosynthesis of acetylcholine in tha rat striatum as studied by in vivo microdialysis. J Neurochem 54:533-539.
40. Leite-Panissi CR, Brentegani MR, Menescal-de-Oliveira L (2004). Cholinergic-opioidergic interaction in the central amygdala induces antinociception in the guinea pig. Braz J Med Biol Res 37:1571-1580.
41. Liu XJ, Salter MW (2005). Purines and pain mechanisms: recent developments. Curr Opin Investig Drugs 6:65-75.
42. Lopez G-Coviella I, Agut J, Von Borstel R, Wurtman RJ (1987). Metabolism of cytidine (5')-diphosphpcholine (CDP-choline) following oral and intravenous administration to the human and the rat. Neurochem Int 11:293-297. (Pubitemid 17152224)
43. Mahmoudi M, Zarrindast MR (2002). Effect of intracerebroventricular injection of GABA receptor agents on morphine-induced antinociception in the formalin test. J Psychopharmacol 16:85-91. (Pubitemid 34273078)
44. Malcangio M, Ghelardini C, Giotti A, Malmberg-Aiello P, Bartolini A (1991). CGP 35348, a new GABAB antagonist, prevents antinociception and muscle-relaxant effect induced by baclofen. Br J Pharmacol 103:1303-1308.
45. Medhurst SJ, Hatcher JP, Hile CJ, Bingham S, Clayton NM, Billinton A, Chessell IP (2008). Activation of the alpha7-nicotinic acetylcholine receptor reverses complete freund adjuvant-induced mechanical hyperalgesia in the rat via a central site of action. J Pain 9:580-587.
46. Millan MJ (2002). Descending control of pain. Prog Neurobiol 66:355-474. (Pubitemid 34606906)
47. Okada M, Nakagawa T, Minami M, Satoh M (2002). Analgesic effects of intrathecal administration of P2Y nucleotide receptor agonists UTP and UDP in normal and neuropathic pain model rats. J Pharmacol Exp Ther 303: 66-73.
48. Papke RL, Bencherif M, Lippiello P (1996). An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the a7 subtype. Neurosci Lett 213:201-204. (Pubitemid 26264379)
49. Randall LO, Selitto JJ (1957). A method for measurement of analgesic activity on inflammed tissue. Archives Internationales De Pharmacodynamie et De Therapie 111:409-419.
50. Rowley TJ, McKinstry A, Greenidge E, Smith W, Flood P (2010). Antinociceptive and anti-inflammatory effects of choline in a mouse model of postoperative pain. Br J Anaesth 105:201-208.
51. Sargent PB (1993). The diversity of neuronal nicotinic acetylcholine receptors. Annu Rev Neurosci 16:403-443. (Pubitemid 23074014)
52. Savci V, Cavun S, Goktalay G, Ulus IH (2002). Cardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic system. Naunyn-Schmiedebergs Archives of Pharmacology 365:388-398. (Pubitemid 34492651)
53. Sawynok J, LaBella FS (1982). On the involvement of GABA in the analgesia produced by baclofen, muscimol and morphine. Neuropharmacology 21:397-403. (Pubitemid 12112495)
54. Seguela P, Wadiche J, Dineleymiller K, Dani JA, Patrick JW (1993). Molecular cloning, functional properties, and distribution of rat brain-alpha7-a nicotinic cation channel highly permeable to calcium. J Neurosci 13:596-604. (Pubitemid 23045143)
55. Suryani LK, Adnjana TAK, Jensen G (1988). Citicoline treatment of memory deficits in elderly people. Int J Geriatr Psychiatry 3:235-236.
56. Taiwo YO, Coderre TJ, Levine JD (1989). The contribution of training to sensitivity in the nociceptive paw-withdrawal test. Brain Res 487:148-151. (Pubitemid 19135176)
57. Ulus IH, Wurtman RJ, Mauron C, Blusztajn JK (1989). Choline increases acetylcholine release and protects against the stimulation induced decrease in phosphatide levels within membranes of rat corpus striatum. Brain Res 484:217-227. (Pubitemid 19100082)
58. Vincler M (2005). Neuronal nicotinic receptors as targets for novel analgesics. Expert Opin Investig Drugs 14:1-8.
59. Vincler M, Wittenauer S, Parker R, Ellison M, Olivera BM, McIntosh JM (2006). Molecular mechanism for analgesia involving specific antagonism of a9 a10 nicotinic acetylcholine receptors. Proc Natl Acad Sci USA 103: 17880-17884. (Pubitemid 44852254)
60. Wada E, Wada K, Boulter J, Deneris E, Heinemann S, Patrick J, Swanson L (1989). Distribution of alpha2, alpha3, alpha4, and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J Comp Neurol 284:314-335. (Pubitemid 19185398)
61. Wang Y, Su DM, Wang RH, Liu Y, Wang H (2005). Antinociceptive effects of choline against acute and inflammatory pain. Neuroscience 132:49-56. (Pubitemid 40380713)
62. Wang JY, Zhao M, Yuan YK, Fan GX, Jia H, Tang JS (2006). The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats. Neuroscience 138:1319-1327. (Pubitemid 43363548)
63. Warach S, Pettigrew LC, Dashe JF, Pullicino P, Lefkowitz DM, Sabounjan L, et al. (2000). Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging, Citicoline 010 investigators. Ann Neurol 48:713-722.
64. Weiss GB (1995). Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline. Life Sciences 56:637-660.
65. Winter CA, Flatakeri L (1965). Reaction thresholds to pressure in edematous hindpaws of rats and responses to analgesic drugs. J Pharmacol Exp Ther 150:165-171.
66. Wurtman RJ (1999). Neuronal death mechanisms in cerebral ischemia: laboratory at the clinic. Rev Neurol 29:524-526. (Pubitemid 29505762)
67. Wurtman RJ, Regan M, Ulus IH, Yu L (2000). Effect of oral CDP-choline on plasma choline and uridine levels in humans. Biochem Pharmacol 60: 989-992.
68. Yaksh TL, Grafe MR, Malkmus S, Rathbun ML, Eisenach JC (1985). Studies on the safety of chronically administered intrathecal neostigmine methylsulfate in rats and dogs. Anesthesiology 82:412-427.
69. Yilmaz MS, Coskun C, Suzer O, Yalcin M, Mutlu D, Savci V (2008). Hypotensive effects of intravenously administered uridine and cytidine in conscious rats: involvement of adenosine receptors. Eur J Pharmacol 584:125-136.
70. Zhao M, Wang JY, Jia H, Tang JS (2006). mu-but not delta-and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced anti-allodynia in a rat neuropathic pain model. Brain Res 1076:68-77. (Pubitemid 43376024)
71. Zhao M, Wang JY, Jia H, Tang JS (2007). Roles of different subtypes of opioid receptors in mediating the ventrolateral orbital cortex opioid-induced inhibition of mirror-neuropathic pain in the rat. Neuroscience 144: 1486-1694.
72. Zarrindast MR, Nami AB, Farzin D (1996). Nicotine potentiates morphine antinociception: a possible cholinergic mechanism. Eur Neuropsychophar-macol 6:27-133.
73. Zarrindast MR, Pazouki M, Nasirsi-Rad S (1997). Involvement of cholinergic and opioid receptor mechanisms in nicotine-induced antinociception. Pharmacol Toxicol 81:209-213. (Pubitemid 27475646)
74. Zimmermann M (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110. (Pubitemid 13058546)
75. Zwart R, Vijverberg HPM (2000). Potentiation and inhibition of neuronal a4b4 nicotinic acetylcholine receptors by choline. Eur J Pharmacol 393:209-214. (Pubitemid 30193418)